Prosensa Holding N.V. To Webcast Conference Call Discussing Full Year 2013 Financial Results And Corporate Update On March 18, 2014

Leiden, The Netherlands, March 5, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that the Company will host a conference call and live audio webcast on Tuesday, March 18, 2014 8:00am Eastern Time (1:00pm Central European Time) to report its full year 2013 financial results and provide a corporate update.

In order to participate in the conference call, please dial 1-877-407-9170 (US Domestic toll-free). International dial-in numbers and an audio webcast can be accessed under "Events & Presentations" through the Investors & Media section of the Prosensa corporate website at   www.prosensa.com .

About Prosensa Holding N.V.

Prosensa (NASDAQ: RNA) is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease.

For more information, visit www.prosensa.com .
CONTACT: Prosensa Holding N.V.         Celia Economides, Senior Director IR & Corporate Communications         Phone: +1 917 975 1983         Email: c.economides@prosensa.nl

Prosensa Holding B.V. Logo

If you liked this article you might like

Sarepta Updates Eteplirsen Study Results, FDA Filing Still on for Mid Year

Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains

Prosensa Holding (RNA) Upgraded From Sell to Hold

The Nominees for Best Biotechnology Co. CEO of 2014 Are...

Biotech Stock Mailbag: Aethlon Medical, Oxigene, Sarepta